145 related articles for article (PubMed ID: 33278960)
1. Helicobacter pylori lipopolysaccharide structural domains and their recognition by immune proteins revealed with carbohydrate microarrays.
Silva LM; Correia VG; Moreira ASP; Domingues MRM; Ferreira RM; Figueiredo C; Azevedo NF; Marcos-Pinto R; Carneiro F; Magalhães A; Reis CA; Feizi T; Ferreira JA; Coimbra MA; Palma AS
Carbohydr Polym; 2021 Feb; 253():117350. PubMed ID: 33278960
[TBL] [Abstract][Full Text] [Related]
2. Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection.
Yokota SI; Amano KI; Shibata Y; Nakajima M; Suzuki M; Hayashi S; Fujii N; Yokochi T
Infect Immun; 2000 Jan; 68(1):151-9. PubMed ID: 10603381
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms.
Monteiro MA; Chan KH; Rasko DA; Taylor DE; Zheng PY; Appelmelk BJ; Wirth HP; Yang M; Blaser MJ; Hynes SO; Moran AP; Perry MB
J Biol Chem; 1998 May; 273(19):11533-43. PubMed ID: 9565568
[TBL] [Abstract][Full Text] [Related]
4. A structural comparison of lipopolysaccharides from two strains of Helicobacter pylori, of which one strain (442) does and the other strain (471) does not stimulate pepsinogen secretion.
Aspinall GO; Mainkar AS; Moran AP
Glycobiology; 1999 Nov; 9(11):1235-45. PubMed ID: 10536039
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains.
Tinnert A; Mattsson A; Bölin I; Dalenbäck J; Hamlet A; Svennerholm AM
Microb Pathog; 1997 Nov; 23(5):285-96. PubMed ID: 9405206
[TBL] [Abstract][Full Text] [Related]
6. Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide.
Yokota Si; Amano Ki; Hayashi S; Kubota T; Fujii N; Yokochi T
Infect Immun; 1998 Jun; 66(6):3006-11. PubMed ID: 9596783
[TBL] [Abstract][Full Text] [Related]
7. Structural studies on lipopolysaccharides of serologically non-typable strains of Helicobacter pylori, AF1 and 007, expressing Lewis antigenic determinants.
Knirel YA; Kocharova NA; Hynes SO; Widmalm G; Andersen LP; Jansson PE; Moran AP
Eur J Biochem; 1999 Nov; 266(1):123-31. PubMed ID: 10542057
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B classification of H. pylori lipopolysaccharides into glycotype families.
Monteiro MA; Appelmelk BJ; Rasko DA; Moran AP; Hynes SO; MacLean LL; Chan KH; Michael FS; Logan SM; O'Rourke J; Lee A; Taylor DE; Perry MB
Eur J Biochem; 2000 Jan; 267(2):305-20. PubMed ID: 10632700
[TBL] [Abstract][Full Text] [Related]
9. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain.
Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V;
Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG antibodies in children and adults reacting with Helicobacter pylori lipopolysaccharides.
Cedzyński M; Amano K; Chmiela M; Lawnik M; Czkwianianc E; Płaneta-Małecka I; Rudnicka W; Kaca W
Arch Immunol Ther Exp (Warsz); 1998; 46(2):79-83. PubMed ID: 9613704
[TBL] [Abstract][Full Text] [Related]
11. Potential role of LPS in the outcome of Helicobacter pylori related diseases.
Grebowska A; Rechciński T; Bak-Romaniszyn L; Czkwianianc E; Moran A; Druszczyńska M; Kowalewicz-Kulbat M; Owczarek A; Dziuba M; Krzemińska-Pakuła M; Płaneta-Małecka I; Rudnicka W; Chmiela M
Pol J Microbiol; 2006; 55(1):25-30. PubMed ID: 16878600
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum antibody titers to Helicobacter pylori lipopolysaccharides, CagA, VacA and partially purified cellular extracts in a Japanese population.
Yokota S; Amano K; Fujii N; Yokochi T
FEMS Microbiol Lett; 2000 Apr; 185(2):193-8. PubMed ID: 10754247
[TBL] [Abstract][Full Text] [Related]
13. A novel Helicobacter pylori cell-surface polysaccharide.
Britton S; Papp-Szabo E; Simala-Grant J; Morrison L; Taylor DE; Monteiro MA
Carbohydr Res; 2005 Jul; 340(9):1605-11. PubMed ID: 15925350
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis(x) and Lewis(y) expression by H. Pylori lipopolysaccharides.
Moran AP; Knirel YA; Senchenkova SN; Widmalm G; Hynes SO; Jansson PE
J Biol Chem; 2002 Feb; 277(8):5785-95. PubMed ID: 11741906
[TBL] [Abstract][Full Text] [Related]
15. Expression of histo-blood group antigens by lipopolysaccharides of Helicobacter pylori strains from asian hosts: the propensity to express type 1 blood-group antigens.
Monteiro MA; Zheng P; Ho B; Yokota S; Amano K; Pan Z; Berg DE; Chan KH; MacLean LL; Perry MB
Glycobiology; 2000 Jul; 10(7):701-13. PubMed ID: 10910974
[TBL] [Abstract][Full Text] [Related]
16. Induction of Mincle by Helicobacter pylori and consequent anti-inflammatory signaling denote a bacterial survival strategy.
Devi S; Rajakumara E; Ahmed N
Sci Rep; 2015 Oct; 5():15049. PubMed ID: 26456705
[TBL] [Abstract][Full Text] [Related]
17. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D.
Khamri W; Moran AP; Worku ML; Karim QN; Walker MM; Annuk H; Ferris JA; Appelmelk BJ; Eggleton P; Reid KB; Thursz MR
Infect Immun; 2005 Nov; 73(11):7677-86. PubMed ID: 16239572
[TBL] [Abstract][Full Text] [Related]
18. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.
Appelmelk BJ; Simoons-Smit I; Negrini R; Moran AP; Aspinall GO; Forte JG; De Vries T; Quan H; Verboom T; Maaskant JJ; Ghiara P; Kuipers EJ; Bloemena E; Tadema TM; Townsend RR; Tyagarajan K; Crothers JM; Monteiro MA; Savio A; De Graaff J
Infect Immun; 1996 Jun; 64(6):2031-40. PubMed ID: 8675304
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and immunogenicity of a Helicobacter pylori lipopolysaccharide-based conjugate.
Monteiro MA; Britton S; Applebee LA; Baqar S
Vaccine; 2011 Apr; 29(17):3098-102. PubMed ID: 21382488
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharides of Helicobacter pylori serogroups O:3 and O:6--structures of a class of lipopolysaccharides with reference to the location of oligomeric units of D-glycero-alpha-D-manno-heptose residues.
Aspinall GO; Monteiro MA; Shaver RT; Kurjanczyk LA; Penner JL
Eur J Biochem; 1997 Sep; 248(2):592-601. PubMed ID: 9346320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
